30
Participants
Start Date
April 30, 2005
Primary Completion Date
June 30, 2010
Study Completion Date
May 31, 2012
GH treatment
GH treatment will be administered at a weekly dose of 0.46 mg/kg/ week, divided into seven daily subcutaneous injections. Subcutaneous injections should be given slowly, in the thigh. In order to prevent lipoatrophy, the injection site should be varied. The injection should be given at bedtime.
Hôpital Robert Debré, Paris
Collaborators (1)
Pfizer
INDUSTRY
Association REMEDE
OTHER